Panel Clinical Supply & Logistics track
Scaling CGT: Cracking the Supply Chain Code
Wed, Feb 5, 2025 · 12:25–12:55 PM EST Rosen Shingle Creek
About this session
Panel Discussion.
The cell and gene therapy (CGT) supply chain presents distinct challenges that require specialized strategies. As demand for CGT continues to grow, scaling production while ensuring product integrity and quality is paramount. Success depends on maintaining cell viability and functionality throughout the process. This panel will focus on practical solutions for overcoming scaling obstacles, preserving product integrity, and fostering collaboration among stakeholders—spanning from patient to manufacturing and back.
Speakers
-
Director, Cell Therapy Operations · AstraZeneca
Panelist